Sophie Richardson

Sophie Richardson is a researcher affiliated with the Cancer Research UK Manchester Institute at the University of Manchester. She holds a Doctor of Philosophy degree and contributes to cancer research, particularly in epigenetics and oncology. Her work aligns with UN Sustainable Development Goal 3 (Good Health and Well-being).

Research focuses include DNA methylation analysis, methylome profiling, and TGFβ signaling regulation in chondrocytes. Key projects involve developing diagnostic tools for cancers of unknown primary origin and monitoring disease relapse in sarcomas using cell-free DNA.

Her recent studies have been widely disseminated, including 139 readers on Mendeley and references in patents. Collaborations span institutions like Vanderbilt University and Memorial Sloan Kettering Cancer Center. No explicit awards are listed, but her work garners significant academic and industry attention.